期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 23, 期 11, 页码 552-559出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2012.06.009
关键词
-
资金
- National Institutes of Health (NIH) [5T32GM083831, CA157996]
- Cancer Prevention and Research Institute of Texas [HIRP100437, RP101243]
- Robert A. Welch Foundation [I-1733]
- Damon-Runyon Cancer Research Foundation
Oncogenes and tumor suppressors regulate cell metabolism. Evidence demonstrates that tumorigenic mutations in these genes tend to orchestrate metabolic activity into a platform that promotes cell survival, growth, and proliferation. Recent work has shown that some metabolic enzymes are also mutated in cancer, and that these mutations may influence malignancy directly. Thus, these enzymes seem to function as oncogenes and tumor suppressors, and would appear to be compelling targets for therapeutic intervention. Here, we review several enzymes mutated in cancer - phosphoglycerate dehydrogenase, isocitrate dehydrogenases 1 and 2, succinate dehydrogenase, and fumarate hydratase - and discuss exciting new work that has begun to pull back the curtain on how mutations in these enzymes influence tumorigenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据